FORT WASHINGTON, Pa., Feb. 16 /PRNewswire/ -- Vitae Pharmaceuticals, Inc. announced today the appointment of Ms. Tina Fiumenero as Senior Vice President, Finance and Administration. Ms. Fiumenero spent 13 years at Bristol-Myers Squibb, where she held a number of finance positions of increasing responsibility spanning: commercial operations, where she led a finance team supporting over $5 billion in sales; manufacturing; and, mergers and acquisitions. Prior to joining Bristol-Myers Squibb, Ms. Fiumenero worked as a financial auditor for Coopers & Lybrand. She holds a B.S. degree in accounting from New York University and is a Certified Public Accountant.
“We are very pleased to welcome Tina to Vitae Pharmaceuticals. Her broad financial experience, business prowess and core leadership skills will strongly contribute to Vitae’s continued maturation as a rapidly growing product-focused company,” said Jeffrey Hatfield, CEO of Vitae Pharmaceuticals. “With two drugs in the clinic, an advancing renin inhibitor collaboration with GSK and progress on Vitae’s next discovery targets, building our financial prowess became the next critical step in our evolution. I am especially pleased to gain the talents of someone as strong as Tina for this important role.”
Ms. Fiumenero added, “I am delighted to join the experienced and successful team at Vitae in their pursuit of innovative, best-in-class new medicines. Based on the progress of the pipeline to date, the company has been able to attract significant investment. I look forward to building additional value for the company and driving the organization to meet its financial goals.”
About Vitae Pharmaceuticals
Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery and development of innovative drugs by advancing its pipeline of product candidates. Vitae is uniquely able to discover innovative compounds by accelerating and enhancing the drug discovery skills and experience of proven drug hunters with world-class, proprietary drug design technologies developed in collaboration with Intel Corporation. Vitae Pharmaceuticals is financed by leading corporate and venture capital investors and is headquartered in Fort Washington, Pennsylvania. For additional information, please visit the company’s website, http://www.vitaepharma.com.
Vitae Pharmaceuticals, Inc.
CONTACT: Kathryn Morris, KMorris PR, +1-845-635-9828, for VitaePharmaceuticals
Web site: http://www.vitaepharma.com/
